This compound is primarily utilized in the field of biomedical research, particularly in the study of cancer and other diseases related to cellular growth and regulation. It functions by simultaneously inhibiting histone deacetylases (HDACs) and the mammalian target of rapamycin (mTOR), two critical pathways involved in cell proliferation, survival, and metabolism. By targeting these pathways, it helps researchers understand the mechanisms of tumor growth and resistance to therapy. Additionally, it is used in preclinical studies to evaluate its potential as a therapeutic agent for treating cancers that are driven by aberrant HDAC and mTOR signaling. Its dual inhibition capability makes it a valuable tool for exploring combination therapies and overcoming drug resistance in cancer treatment.